BCL2 and ovarian carcinoma: Elevated levels of the anti-apoptotic protein Bcl-2 were present in urine from patients with ovarian cancer, independently from tumor stage, grade, and size, and differentiated between healthy and ovarian cancer patients with an AUC of 0.9 [130].